U Op Cregen Med
Medical Technology
- Website
- uopcregenmed.com · all feeds from this site
- Feed URL
http://uopcregenmed.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
The Dawn of Precision Oncology: Custom mRNA Vaccines Enter Clinical Phases
The landscape of cancer therapy is undergoing a tectonic shift as personalized mRNA vaccines enter advanced clinical trial stages. Unlike traditional modern treatments that broadly target rapidly dividing cells, these custom-engineered formulations are designed around the…
-
Microplastic Bioaccumulation Identified in Deep Human Tissue Samples
In a sobering revelation for global public health, multi-center laboratory analyses have confirmed the presence of polymer microparticles embedded within deep human vascular and cardiac tissues. Utilizing advanced raman spectroscopy and pyrolysis gas chromatography, researchers…
-
CRISPR Base Editing Reverses Inherited Metabolic Syndrome in Primates
Biomedical engineering has achieved a monumental milestone by successfully deploying precise base editing techniques to cure a hereditary metabolic dysfunction in non-human primates. Classic genetic interventions often rely on double-stranded DNA breaks, which introduce a higher…
-
Artificial Intelligence Outperforms Traditional Screening in Early Sepsis Detection
Clinical validation studies conducted across major trauma centers demonstrate that deep-learning predictive algorithms can identify systemic inflammatory response syndromes up to six hours before classic physiological symptoms manifest. Sepsis remains a primary driver of…
-
Gut Microbiome Dysbiosis Directly Linked to Autoimmune Neuroinflammation
Emerging laboratory data have established a definitive causal pathway mapping how specific intestinal microbial populations influence the severity of central nervous system autoimmune conditions. Investigators identified that a profound depletion of short-chain fatty…
-
Monoclonal Antibody Breakthrough Slows Cognitive Decline in Early Alzheimer Disease
Global neurological research has verified that a novel class of monoclonal antibodies successfully targets and clears amyloid-beta oligomers, significantly slowing the trajectory of early-stage dementia. In rigorous phase-three clinical trials, participants receiving regular…